thalidomide has been researched along with Acute Necrotizing Pancreatitis in 1 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Malleo, G | 1 |
Mazzon, E | 1 |
Genovese, T | 1 |
Di Paola, R | 1 |
MuiĆ , C | 1 |
Crisafulli, C | 1 |
Siriwardena, AK | 1 |
Cuzzocrea, S | 1 |
1 other study available for thalidomide and Acute Necrotizing Pancreatitis
Article | Year |
---|---|
Effects of thalidomide in a mouse model of cerulein-induced acute pancreatitis.
Topics: Animals; Apoptosis; Ceruletide; Disease Models, Animal; Immunologic Factors; Intercellular Adhesion | 2008 |